As we anticipate the 2026 flu season, there's an intriguing mix of optimism and uncertainty in the air. The latest data suggests a promising start, with reported influenza cases halving compared to the unpredictable 2025 season. However, experts urge us not to let our guard down, emphasizing the importance of prevention and vaccination.
The 2026 Flu Season: A Balancing Act
The Australian Science Media Centre hosted a media briefing on May 5, 2026, bringing together leading experts to discuss the upcoming flu season. Professor Patrick Reading, Director of the WHO Collaborating Centre for Reference and Research on Influenza at the Doherty Institute, joined Dr. Marsha Somi and Professor Kristine Macartney, both key figures in Australia's disease control and immunisation research.
Data Sources and Insights
The National Disease Surveillance System (NNDSS) and the Australian Respiratory Surveillance Report are our primary sources of data. Dr. Somi highlighted that over 29,000 influenza cases have been reported to the NNDSS this year, a significant drop from the high rates seen in 2025. This decline is particularly notable given that 2025 witnessed the highest number of recorded cases since record-keeping began in 1991.
Professor Reading attributed the high number of cases in 2025 to an extended flu season that peaked beyond the usual winter months. The emergence of the A/H3N2 Subclade K virus, which dominated the Northern Hemisphere's flu season, played a crucial role.
Global Surveillance and Vaccine Development
The WHO Global Influenza Surveillance and Response System continuously monitors virus strains worldwide. This system meets biannually to provide recommendations six months before vaccine production. Despite the vaccine being mismatched to the dominant Subclade K in the Northern Hemisphere, it still offered protection against severe outcomes. For the Southern Hemisphere season, the vaccine composition was updated to better match the K variant.
Professor Reading acknowledged the uncertainty of the past year due to limited communication between the WHO and the US Centers for Disease Control and Prevention (CDC) influenza division. However, he remains hopeful about future collaboration, as the CDC has actively shared data from the US and other countries, contributing to vaccine strain selection meetings.
Influenza: A Threat to All
Dr. Macartney emphasized that influenza is not just a risk for those with pre-existing health conditions. It can cause serious illness, hospitalization, and even death in perfectly healthy individuals of all ages. Almost half a million lab tests came back positive for influenza in 2025, and this is likely just the visible tip of the iceberg, as many people don't seek medical attention or testing.
The decline in vaccine confidence among parents is a cause for concern, with only one in four children aged six months to five years vaccinated. The average age of children admitted to the hospital for influenza is just five years old, highlighting the vulnerability of young, healthy individuals.
Needle-Free Vaccination: A Game-Changer?
The introduction of a needle-free, nasal spray flu vaccine in Australia this year offers hope for increased vaccination rates among children. This vaccine, which has been in use for decades in the US, Canada, and the UK, has a proven track record of effectiveness, impact on transmission, and safety. Dr. Macartney believes that the availability of this vaccine for children over two years old could lead to a much-needed uptick in children's vaccination rates.
The Role of Healthcare Providers
General practitioners play a vital role in reinforcing key winter season messages and connecting with patients on a personal level. Dr. Macartney highlighted the potential for misconceptions fueled by false information circulating on social media. Healthcare providers have the unique ability to spend time with patients, addressing their concerns and providing accurate, evidence-based information.
Conclusion: A Call to Action
The 2026 flu season presents an opportunity for us to take proactive measures to protect ourselves and our communities. The National Immunisation Program recommends annual influenza vaccination before the start of the flu season. By staying informed, seeking reliable sources of information, and taking advantage of the available vaccines, we can collectively reduce the impact of respiratory infections and keep ourselves and our loved ones safe.
Personally, I believe that staying vigilant and informed is key. While the data suggests a promising start to the 2026 flu season, we must remember that influenza is an unpredictable virus. By taking preventive measures and supporting vaccination efforts, we can contribute to a healthier and more resilient community.
